↓ Skip to main content

A multi-center phase II study of high dose interleukin-2 sequenced with vemurafenib in patients with BRAF-V600 mutation positive metastatic melanoma

Overview of attention for article published in Journal for Immunotherapy of Cancer, July 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (54th percentile)

Mentioned by

twitter
5 tweeters

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
24 Mendeley